San Diego, CA, United States of America

Jose Cardenas


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jose Cardenas

Introduction

Jose Cardenas is a notable inventor based in San Diego, CA. He has made significant contributions to the field of cell regulatory factors through his innovative research and patents. His work has implications for cancer research and therapeutic development.

Latest Patents

Jose Cardenas holds a patent titled "Decorin fragments inhibiting cell regulatory factors." This invention provides a method for inhibiting the activity of a cell regulatory factor by contacting it with a purified polypeptide. The polypeptide comprises a cell regulatory factor binding domain of a protein characterized by a leucine-rich repeat of about 24 amino acids. Specifically, the invention relates to the ability of decorin, a 40,000 dalton protein, to bind TGF-beta. The patent also introduces a novel cell regulatory factor designated MRF and outlines methods for identifying, detecting, and purifying cell regulatory factors and proteins that affect their activity. He has 1 patent to his name.

Career Highlights

Jose Cardenas is associated with the La Jolla Cancer Research Foundation, where he continues to advance his research in cell regulatory factors. His work is pivotal in understanding the mechanisms that govern cell behavior, particularly in the context of cancer.

Collaborations

Throughout his career, Jose has collaborated with esteemed colleagues such as Erkki I Ruoslahti and Michael D Pierschbacher. These collaborations have enriched his research and contributed to the advancement of knowledge in the field.

Conclusion

Jose Cardenas is a distinguished inventor whose work on decorin fragments has the potential to impact cancer research significantly. His contributions to the understanding of cell regulatory factors are invaluable, and his ongoing research promises to yield further innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…